Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erhard Seifried

Showing results (81-90 of 189) with videos related to

Pageof 19
Sort By:
Experimental Hematology|February 26, 2005
Mechanisms of resistance to natural killer cell-mediated cytotoxicity in acute lymphoblastic leukemiaAnnette Romanski, Gesine Bug, Sven Becker, et al.
Transfusion|October 12, 2002
Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central EuropeW Kurt Roth, Marijke Weber, Sylvia Buhr, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 30, 2005
gammaAla82Gly represents a common fibrinogen gamma-chain variant in CaucasiansVytautas Ivaskevicius, Egle Jusciute, Michael Steffens, et al.
Thrombosis and Haemostasis|June 24, 2004
Confocal microscopy analysis of native, full length and B-domain deleted coagulation factor VIII trafficking in mammalian cellsSven Becker, Jeremy C Simpson, Rainer Pepperkok, et al.
Thrombosis and Haemostasis|November 8, 2008
Modelling and expression studies of two novel mutations causing factor V deficiencyDaniel Delev, Anna Pavlova, Stefan Heinz, et al.
Transfusion|December 16, 2010
Automatic interface-controlled apheresis collection of stem/progenitor cells: results from an autologous donor validation trial of a novel stem cell apheresis devicePeter Reinhardt, Susanne Brauninger, Heike Bialleck, et al.
Transfusion|March 25, 2009
Cellular immune response to hepatitis C virus (HCV) in nonviremic blood donors with indeterminate anti-HCV reactivityTobias Hitziger, Michael Schmidt, Volkmar Schottstedt, et al.
Stem Cells and Development|October 3, 2013
Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparationsChristopher Ungerer, Patricia Quade-Lyssy, Heinfried H Radeke, et al.
Journal of Cellular and Molecular Medicine|March 24, 2016
CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignanciesAnnette Romanski, Christoph Uherek, Gesine Bug, et al.
Transfusion|February 4, 2015
Red blood cell depletion from bone marrow and peripheral blood buffy coat: a comparison of two new and three established technologiesNadine Sorg, Carolin Poppe, Milica Bunos, et al.
Pageof 19

Showing results (81-90 of 189) with videos related to

Sort By:
Pageof 19
Experimental Hematology|February 26, 2005
Mechanisms of resistance to natural killer cell-mediated cytotoxicity in acute lymphoblastic leukemiaAnnette Romanski, Gesine Bug, Sven Becker, et al.
Transfusion|October 12, 2002
Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central EuropeW Kurt Roth, Marijke Weber, Sylvia Buhr, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 30, 2005
gammaAla82Gly represents a common fibrinogen gamma-chain variant in CaucasiansVytautas Ivaskevicius, Egle Jusciute, Michael Steffens, et al.
Thrombosis and Haemostasis|June 24, 2004
Confocal microscopy analysis of native, full length and B-domain deleted coagulation factor VIII trafficking in mammalian cellsSven Becker, Jeremy C Simpson, Rainer Pepperkok, et al.
Thrombosis and Haemostasis|November 8, 2008
Modelling and expression studies of two novel mutations causing factor V deficiencyDaniel Delev, Anna Pavlova, Stefan Heinz, et al.
Transfusion|December 16, 2010
Automatic interface-controlled apheresis collection of stem/progenitor cells: results from an autologous donor validation trial of a novel stem cell apheresis devicePeter Reinhardt, Susanne Brauninger, Heike Bialleck, et al.
Transfusion|March 25, 2009
Cellular immune response to hepatitis C virus (HCV) in nonviremic blood donors with indeterminate anti-HCV reactivityTobias Hitziger, Michael Schmidt, Volkmar Schottstedt, et al.
Stem Cells and Development|October 3, 2013
Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparationsChristopher Ungerer, Patricia Quade-Lyssy, Heinfried H Radeke, et al.
Journal of Cellular and Molecular Medicine|March 24, 2016
CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignanciesAnnette Romanski, Christoph Uherek, Gesine Bug, et al.
Transfusion|February 4, 2015
Red blood cell depletion from bone marrow and peripheral blood buffy coat: a comparison of two new and three established technologiesNadine Sorg, Carolin Poppe, Milica Bunos, et al.
Pageof 19